Annual Total Liabilities
$21.62 M
+$1.22 M+5.97%
December 31, 2022
Summary
- As of February 10, 2025, NLTX annual total liabilities is $21.62 million, with the most recent change of +$1.22 million (+5.97%) on December 31, 2022.
- During the last 3 years, NLTX annual total liabilities has risen by +$16.28 million (+305.12%).
Performance
NLTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$14.35 M
-$78.00 K-0.54%
September 30, 2023
Summary
- As of February 10, 2025, NLTX quarterly total liabilities is $14.35 million, with the most recent change of -$78.00 thousand (-0.54%) on September 30, 2023.
- Over the past year, NLTX quarterly total liabilities has dropped by -$6.58 million (-31.43%).
Performance
NLTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NLTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.0% | -31.4% |
| 3 y3 years | +305.1% | -32.8% |
| 5 y5 years | +88.9% | +29.4% |
NLTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -5.6% | -33.6% | at low |
| 5 y | 5-year | at high | -75.3% | -33.6% | -62.8% |
| alltime | all time | -73.4% | -77.2% | -82.4% | -90.6% |
Neoleukin Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $14.35 M(-0.5%) |
| Jun 2023 | - | $14.43 M(-15.6%) |
| Mar 2023 | - | $17.10 M(-20.9%) |
| Dec 2022 | $21.62 M(+6.0%) | $21.62 M(+3.3%) |
| Sep 2022 | - | $20.93 M(+3.0%) |
| Jun 2022 | - | $20.31 M(+6.7%) |
| Mar 2022 | - | $19.03 M(-6.7%) |
| Dec 2021 | $20.40 M(+5.7%) | $20.40 M(-3.2%) |
| Sep 2021 | - | $21.07 M(+5.6%) |
| Jun 2021 | - | $19.95 M(-5.6%) |
| Mar 2021 | - | $21.14 M(+9.5%) |
| Dec 2020 | $19.30 M(+261.8%) | $19.30 M(-9.6%) |
| Sep 2020 | - | $21.35 M(+28.4%) |
| Jun 2020 | - | $16.63 M(+4.4%) |
| Mar 2020 | - | $15.93 M(+198.6%) |
| Dec 2019 | $5.34 M(+7.9%) | $5.34 M(+83.0%) |
| Sep 2019 | - | $2.92 M(+106.2%) |
| Jun 2019 | - | $1.41 M(-63.7%) |
| Mar 2019 | - | $3.89 M(-21.3%) |
| Dec 2018 | $4.95 M | $4.95 M(-55.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $11.09 M(-19.3%) |
| Jun 2018 | - | $13.75 M(+40.3%) |
| Mar 2018 | - | $9.80 M(-14.4%) |
| Dec 2017 | $11.44 M(+17.8%) | $11.44 M(+52.4%) |
| Sep 2017 | - | $7.51 M(-13.4%) |
| Jun 2017 | - | $8.68 M(+35.9%) |
| Mar 2017 | - | $6.39 M(-34.3%) |
| Dec 2016 | $9.72 M(+97.4%) | $9.72 M(+11.6%) |
| Sep 2016 | - | $8.71 M(+1.1%) |
| Jun 2016 | - | $8.61 M(+47.7%) |
| Mar 2016 | - | $5.83 M(+18.4%) |
| Dec 2015 | $4.92 M(-6.7%) | $4.92 M(+23.0%) |
| Sep 2015 | - | $4.00 M(-1.2%) |
| Jun 2015 | - | $4.05 M(-19.8%) |
| Mar 2015 | - | $5.05 M(-4.2%) |
| Dec 2014 | $5.28 M(-93.5%) | $5.28 M(+13.8%) |
| Sep 2014 | - | $4.64 M(+57.7%) |
| Jun 2014 | - | $2.94 M(+117.4%) |
| Mar 2014 | - | $1.35 M(-98.3%) |
| Dec 2013 | $81.34 M(+52.2%) | $81.34 M |
| Dec 2012 | $53.44 M | - |
FAQ
- What is Neoleukin Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual total liabilities year-on-year change?
- What is Neoleukin Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly total liabilities year-on-year change?
What is Neoleukin Therapeutics annual total liabilities?
The current annual total liabilities of NLTX is $21.62 M
What is the all time high annual total liabilities for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual total liabilities is $81.34 M
What is Neoleukin Therapeutics annual total liabilities year-on-year change?
Over the past year, NLTX annual total liabilities has changed by +$1.22 M (+5.97%)
What is Neoleukin Therapeutics quarterly total liabilities?
The current quarterly total liabilities of NLTX is $14.35 M
What is the all time high quarterly total liabilities for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly total liabilities is $81.34 M
What is Neoleukin Therapeutics quarterly total liabilities year-on-year change?
Over the past year, NLTX quarterly total liabilities has changed by -$6.58 M (-31.43%)